de Creative Planning BioMarin Pharmaceuticals BMRN Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 8.76 M | Comprar |
153,161
+40,061
| +35% | +USD 2.19 M | 0.01% | 981 |
|
|
2026
Q1 | USD 6.39 M | Comprar |
113,100
+45,259
| +67% | +USD 2.64 M | ﹤0.01% | 1006 |
|
|
2025
Q4 | USD 4.03 M | Comprar |
67,841
+33,476
| +97% | +USD 1.82 M | ﹤0.01% | 1163 |
|
|
2025
Q3 | USD 1.86 M | Comprar |
34,365
+11,405
| +50% | +USD 652 k | ﹤0.01% | 1610 |
|
|
2025
Q2 | USD 1.26 M | Vender |
22,960
-3,010
| -12% | -USD 177 k | ﹤0.01% | 1665 |
|
|
2025
Q1 | USD 1.84 M | Vender |
25,970
-7,791
| -23% | -USD 524 k | ﹤0.01% | 1231 |
|
|
2024
Q4 | USD 2.22 M | Comprar |
33,761
+19,461
| +136% | +USD 1.3 M | ﹤0.01% | 1068 |
|
|
2024
Q3 | USD 1.01 M | Comprar |
14,300
+2,475
| +21% | +USD 207 k | ﹤0.01% | 1506 |
|
|
2024
Q2 | USD 974 k | Comprar |
11,825
+524
| +5% | +USD 43.6 k | ﹤0.01% | 1416 |
|
|
2024
Q1 | USD 987 k | Vender |
11,301
-1
| -0% | -USD 90 | ﹤0.01% | 1349 |
|
|
2023
Q4 | USD 1.09 M | Comprar |
11,302
+2,736
| +32% | +USD 242 k | ﹤0.01% | 1183 |
|
|
2023
Q3 | USD 758 k | Comprar |
8,566
+507
| +6% | +USD 45.1 k | ﹤0.01% | 1298 |
|
|
2023
Q2 | USD 699 k | Comprar |
8,059
+1,074
| +15% | +USD 101 k | ﹤0.01% | 1339 |
|
|
2023
Q1 | USD 679 k | Comprar |
6,985
+163
| +2% | +USD 16.9 k | ﹤0.01% | 1297 |
|
|
2022
Q4 | USD 706 k | Comprar |
6,822
+532
| +8% | +USD 49.9 k | ﹤0.01% | 1225 |
|
|
2022
Q3 | USD 533 k | Comprar |
6,290
+53
| +0.8% | +USD 4.72 k | ﹤0.01% | 1295 |
|
|
2022
Q2 | USD 517 k | Comprar |
6,237
+2,744
| +79% | +USD 218 k | ﹤0.01% | 1297 |
|
|
2022
Q1 | USD 269 k | Vender |
3,493
-1,302
| -27% | -USD 109 k | ﹤0.01% | 1702 |
|
|
2021
Q4 | USD 424 k | Comprar |
4,795
+21
| +0.4% | +USD 1.73 k | ﹤0.01% | 1402 |
|
|
2021
Q3 | USD 369 k | Comprar |
4,774
+251
| +6% | +USD 19.8 k | ﹤0.01% | 1471 |
|
|
2021
Q2 | USD 377 k | Vender |
4,523
-438
| -9% | -USD 34.7 k | ﹤0.01% | 1435 |
|
|
2021
Q1 | USD 375 k | Vender |
4,961
-597
| -11% | -USD 48.8 k | ﹤0.01% | 1637 |
|
|
2020
Q4 | USD 487 k | Vender |
5,558
-579
| -9% | -USD 45.9 k | ﹤0.01% | 1333 |
|
|
2020
Q3 | USD 467 k | Comprar |
6,137
+1,020
| +20% | +USD 103 k | ﹤0.01% | 1171 |
|
|
2020
Q2 | USD 631 k | Vender |
5,117
-813
| -14% | -USD 80.8 k | ﹤0.01% | 925 |
|
|
2020
Q1 | USD 501 k | Vender |
5,930
-3,774
| -39% | -USD 325 k | ﹤0.01% | 943 |
|
|
2019
Q4 | USD 820 k | Vender |
9,704
-92
| -0.9% | -USD 6.95 k | ﹤0.01% | 878 |
|
|
2019
Q3 | USD 660 k | Comprar |
9,796
+132
| +1% | +USD 10.2 k | ﹤0.01% | 930 |
|
|
2019
Q2 | USD 828 k | Vender |
9,664
-5,230
| -35% | -USD 447 k | ﹤0.01% | 840 |
|
|
2019
Q1 | USD 1.32 M | Vender |
14,894
-3,142
| -17% | -USD 291 k | ﹤0.01% | 623 |
|
|
2018
Q4 | USD 1.54 M | Comprar |
18,036
+13,398
| +289% | +USD 1.27 M | 0.01% | 496 |
|
|
2018
Q3 | USD 450 k | Vender |
4,638
-507
| -10% | -USD 50.6 k | ﹤0.01% | 1137 |
|
|
2018
Q2 | USD 485 k | Vender |
5,145
-131
| -2% | -USD 11.5 k | ﹤0.01% | 1086 |
|
|
2018
Q1 | USD 428 k | Vender |
5,276
-916
| -15% | -USD 78.6 k | ﹤0.01% | 1157 |
|
|
2017
Q4 | USD 552 k | Comprar |
6,192
+2,129
| +52% | +USD 185 k | ﹤0.01% | 1019 |
|
|
2017
Q3 | USD 378 k | Comprar |
4,063
+815
| +25% | +USD 72 k | ﹤0.01% | 1189 |
|
|
2017
Q2 | USD 295 k | Vender |
3,248
-10,192
| -76% | -USD 927 k | ﹤0.01% | 1297 |
|
|
2017
Q1 | USD 1.18 M | Comprar |
13,440
+100
| +0.7% | +USD 8.9 k | 0.01% | 608 |
|
|
2016
Q4 | USD 1.1 M | Vender |
13,340
-446
| -3% | -USD 38.4 k | 0.01% | 590 |
|
|
2016
Q3 | USD 1.28 M | Comprar |
13,786
+10,211
| +286% | +USD 962 k | 0.01% | 510 |
|
|
2016
Q2 | USD 278 k | Comprar |
3,575
+825
| +30% | +USD 70.1 k | ﹤0.01% | 1091 |
|
|
2016
Q1 | USD 227 k | Comprar |
2,750
+20
| +0.7% | +USD 1.63 k | ﹤0.01% | 1146 |
|
|
2015
Q4 | USD 286 k | Comprar |
2,730
+335
| +14% | +USD 35 k | ﹤0.01% | 1012 |
|
|
2015
Q3 | USD 252 k | Comprar |
+2,395
| Nuevas | +USD 320 k | ﹤0.01% | 1059 |
|
|
2015
Q2 | – | Vender |
-1,770
| Cerradas | -USD 221 k | – | 1324 |
|
|
2015
Q1 | USD 221 k | Vender |
1,770
-9,409
| -84% | -USD 997 k | ﹤0.01% | 1135 |
|
|
2014
Q4 | USD 1.01 M | Comprar |
11,179
+7,437
| +199% | +USD 618 k | 0.01% | 446 |
|
|
2014
Q3 | USD 270 k | Vender |
3,742
-3,778
| -50% | -USD 248 k | ﹤0.01% | 917 |
|
|
2014
Q2 | USD 468 k | Comprar |
7,520
+3,979
| +112% | +USD 240 k | 0.01% | 670 |
|
|
2014
Q1 | USD 242 k | Comprar |
3,541
+1,871
| +112% | +USD 138 k | ﹤0.01% | 909 |
|
|
2013
Q4 | USD 117 k | Vender |
1,670
-130
| -7% | -USD 8.83 k | ﹤0.01% | 1115 |
|
|
2013
Q3 | USD 130 k | Vender |
1,800
-11,434
| -86% | -USD 760 k | ﹤0.01% | 964 |
|
|
2013
Q2 | USD 738 k | Comprar |
+13,234
| Nuevas | +USD 825 k | 0.02% | 301 |
|
Otros fondos que tienen BMRN en su cartera
Posición de Creative Planning en BMRN: resumen de T2 2026
Creative Planning aumentó su participación en BioMarin Pharmaceuticals (BMRN) en 35% durante T2 2026, al comprar aproximadamente USD 2.19 M y elevar la posición a 153,161 acciones con un valor de USD 8.76 M. La posición representa 0.01% de la cartera y ocupa el puesto #981.
Creative Planning reportó por primera vez una posición en BMRN en T2 2013 y la ha mantenido durante 52 trimestres desde entonces. Al cierre de T2 2026, 566 fondos que sigue Wall St. Rank mantienen una posición en BMRN.
- Al cierre de T2 2026, Creative Planning tenía 153,161 acciones de BioMarin Pharmaceuticals con un valor de USD 8.76 M.
- Creative Planning compró 40,061 acciones de BioMarin Pharmaceuticals en T2 2026, por un monto estimado de USD 2.19 M.
- BioMarin Pharmaceuticals representó 0.01% de la cartera de Creative Planning en T2 2026 y fue su posición número 981.
- Creative Planning reportó por primera vez una posición en BioMarin Pharmaceuticals en T2 2013 y la ha mantenido durante 52 trimestres desde entonces.
- Al cierre de T2 2026, 566 fondos que sigue Wall St. Rank tenían BioMarin Pharmaceuticals en cartera.
Según el Informe 13F de Creative Planning correspondiente a T2 2026, presentado el 13 ago 2026.